BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Whitney Ijem does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 RCKTRocket Pharmaceuticals Inc | Buy | $11.00 | Jun 2025 | −12.7% | Miss |
 TSHATaysha Gene Therapies Inc | Buy | $11.00 | Jun 2025 | +86.3% | Miss |
| TSHATaysha Gene Therapies Inc | Buy | $9.00 | May 2025 | +84.8% | Miss |
 ARCTArcturus Therapeutics Holdings Inc | Buy | $66.00 | May 2025 | −39.8% | Miss |
 TNYATenaya Therapeutics Inc | Buy | $6.00 | Mar 2025 | +16.8% | Miss |
| ARCTArcturus Therapeutics Holdings Inc | Buy | $68.00 | Mar 2025 | −49.0% | Miss |
 RAREUltragenyx | Buy | $136.00 | Feb 2025 | −63.4% | Miss |
 PASGPassage Bio Inc | Buy | $13.00 | Nov 2024 | −23.7% | Miss |
| RAREUltragenyx | Buy | $121.00 | Nov 2024 | −37.1% | Miss |
| RAREUltragenyx | Buy | $121.00 | Nov 2024 | −38.3% | Miss |
| TNYATenaya Therapeutics Inc | Buy | $16.00 | Oct 2024 | +5.2% | Miss |
| TNYATenaya Therapeutics Inc | Buy | $16.00 | May 2024 | −82.8% | Miss |
| PASGPassage Bio Inc | Buy | $13.00 | May 2024 | −68.6% | Miss |
| TNYATenaya Therapeutics Inc | Buy | $18.00 | Mar 2024 | −88.5% | Miss |
| PASGPassage Bio Inc | Buy | $14.00 | Mar 2024 | −76.6% | Miss |
 RYTMRhythm Pharmaceuticals Inc | Buy | — | Jan 2023 | +31.8% | — |
| RAREUltragenyx | Buy | $90.00 | Jan 2023 | −2.4% | Miss |
| PASGPassage Bio Inc | Buy | $8.00 | Nov 2022 | −41.1% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.